Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Shares (Diluted)

Shares (Diluted) at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
164.9M+3.9%
ALN
Alnylam PharmaceuticalsALNY
138.2M+6.6%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
96.1M+11.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
103.3M+17.4%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
418.5M+29.6%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
81.3M+33.1%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.17B+106%

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's shares (diluted)?
Intellia Therapeutics (NTLA) reported shares (diluted) of 118.5M in Q1 2026.
How has Intellia Therapeutics's shares (diluted) changed year-over-year?
Intellia Therapeutics's shares (diluted) increased by 14.5% year-over-year, from 103.5M to 118.5M.
What is the long-term trend for Intellia Therapeutics's shares (diluted)?
Over 4 years (2021 to 2025), Intellia Therapeutics's shares (diluted) has grown at a 11.1% compound annual growth rate (CAGR), from 279.9M to 425.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.